The S&P/ASX 200 Index (ASX: XJO) is on form again on Tuesday and is pushing higher. In afternoon trade, the benchmark index is up 0.3% to 7,769.8 points.
Four ASX shares that are rising more than most today are listed below. Here's why they are pushing higher:
Accent Group Ltd (ASX: AX1)
The Accent Group share price is up 5% to $1.90. This morning, Accent announced that it will be granted the right to launch and operate the Sports Direct business (including online) in the ANZ region for an initial 25-year term. The company revealed that it has plans for an initial roll-out of at least 50 Sports Direct stores over the next 6 years. However, it ultimately sees an opportunity for 100 plus Sports Direct stores in the region. Accent CEO, Daniel Agostinelli said: "After extensive discussions, we are very pleased to announce a long-term strategic relationship with Frasers to open Sports Direct in Australia and New Zealand. Sports Direct is one of the leading sporting goods retailing businesses globally. Frasers and Accent see a significant opportunity to bring a new and exciting global sports business to the Australian and New Zealand markets."
DroneShield Ltd (ASX: DRO)
The DroneShield share price is up a further 11% to $1.15. This counter drone technology company's shares have been storming higher this week after announcing new contract wins. The company received a package of five separate contracts totalling $32.2 million. These contracts were placed by an in-country reseller for delivery to a military end customer in an Asian Pacific country. Bell Potter was impressed. So much so, this morning the broker retained its buy rating and lifted its price target to $1.30 from $1.10. It said: "Current industry tailwinds and DRO's strong performance YTD gives us confidence that customer activity is increasing following a brief pause around the US election last year."
EBR Systems Inc (ASX: EBR)
The EBR Systems share price is up 5% to $1.47. On Monday, this medical device company announced FDA approval for the WiSE CRT System. It is the world's first and only lead-less solution for left ventricular endocardial pacing. Management notes that for the first time, clinicians can deliver cardiac resynchronisation therapy without leads. EBR will initially target a US$3.6 billion addressable market across high-risk upgrade, lead failure, and lead-less CRT expansion categories, with future opportunity to expand into other indications.
Titomic Ltd (ASX: TTT)
The Titomic share price is up 14% to 24 cents. The catalyst for this is news that the cold spray additive manufacturing technology company is collaborating with Northrop Grumman to develop and manufacture high-performance pressure vessels. Management notes that this work is a pivotal step in Titomic's strategic shift toward high-value collaborations in aerospace and defense, demonstrating its commitment to delivering integrated solutions for mission-critical components. It also highlights that the collaboration leverages Titomic's expertise in cold spray systems and Northrop Grumman's leadership in aerospace and defense. They have a shared goal of enhancing the performance, durability, and significantly reducing the production schedule of critical pressure vessels.
